Education
About Us
Working with TipRanks
Follow Us
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
Total Valuation
Prime Medicine, Inc. has a market cap or net worth of $691.51M. The enterprise value is $744.75M.
Market Cap$691.51M
Enterprise Value$744.75M
Share Statistics
Prime Medicine, Inc. has 180,552,190 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding180,552,190
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Prime Medicine, Inc.’s return on equity (ROE) is -1.66 and return on invested capital (ROIC) is -66.48%.
Return on Equity (ROE)-1.66
Return on Assets (ROA)-0.59
Return on Invested Capital (ROIC)-66.48%
Return on Capital Employed (ROCE)-0.68
Revenue Per Employee21.64K
Profits Per Employee-939.92K
Employee Count214
Asset Turnover0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Prime Medicine, Inc. is ―. Prime Medicine, Inc.’s PEG ratio is 0.14.
PE Ratio―
PS Ratio111.44
PB Ratio4.27
Price to Fair Value4.27
Price to FCF-3.09
Price to Operating Cash Flow-3.50
PEG Ratio0.14
Income Statement
In the last 12 months, Prime Medicine, Inc. had revenue of 4.63M and earned -201.14M in profits. Earnings per share was -1.35.
Revenue4.63M
Gross Profit-2.69M
Operating Income-208.35M
Pretax Income-201.14M
Net Income-201.14M
EBITDA-195.76M
Earnings Per Share (EPS)-1.35
Cash Flow
In the last 12 months, operating cash flow was -162.56M and capital expenditures -4.53M, giving a free cash flow of -167.09M billion.
Operating Cash Flow-162.56M
Free Cash Flow-167.09M
Free Cash Flow per Share-0.93
Dividends & Yields
Prime Medicine, Inc. pays an annual dividend of $0.8, resulting in a dividend yield of ―
Dividend Per Share$0.8
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.08
52-Week Price Change100.52%
50-Day Moving Average3.84
200-Day Moving Average3.83
Relative Strength Index (RSI)53.21
Average Volume (3m)2.82M
Important Dates
Prime Medicine, Inc. upcoming earnings date is May 7, 2026, Before Open (Confirmed).
Last Earnings DateMar 3, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Prime Medicine, Inc. as a current ratio of 4.84, with Debt / Equity ratio of 96.33%
Current Ratio4.84
Quick Ratio4.84
Debt to Market Cap0.23
Net Debt to EBITDA-0.27
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Prime Medicine, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Prime Medicine, Inc. EV to EBITDA ratio is -2.91, with an EV/FCF ratio of -3.41.
EV to Sales122.97
EV to EBITDA-2.91
EV to Free Cash Flow-3.41
EV to Operating Cash Flow-3.50
Balance Sheet
Prime Medicine, Inc. has $177.68M in cash and marketable securities with $116.43M in debt, giving a net cash position of $61.25M billion.
Cash & Marketable Securities$177.68M
Total Debt$116.43M
Net Cash$61.25M
Net Cash Per Share$0.34
Tangible Book Value Per Share$0.81
Margins
Gross margin is -930.44%, with operating margin of -4498.06%, and net profit margin of -4342.44%.
Gross Margin-930.44%
Operating Margin-4498.06%
Pretax Margin-4342.44%
Net Profit Margin-4342.44%
EBITDA Margin-4226.21%
EBIT Margin-4342.44%
Analyst Forecast
The average price target for Prime Medicine, Inc. is $5.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.50
Price Target Upside35.80% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast647.13%
EPS Growth Forecast26.79%